Clinical Trial Update: Empagliflozin and Cardiac Remodelling in People Without Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing empagliflozin for cardiac remodeling in people without diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Left Ventricular Hypertrophy

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Unity Health Toronto | Conditions: Cardiovascular Diseases, Left Ventricular Hypertrophy | Phase 4 | Status: COMPLETED